Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

DX-88 granted orphan drug designation by FDA

Feb. 17, 2003

Repligen studies triacetyluridine for mitochondrial disease in new phase I/II trial

Feb. 17, 2003

Endovasc sponsors preliminary Liprostin study

Feb. 17, 2003

AstraZeneca submits data to support Crestor NDA

Feb. 17, 2003

Good pregnancy rates reported with ganirelix in IVF/ICSI

Feb. 17, 2003

Morishita Jintan claims plant extracts with antidiabetic activity

Feb. 17, 2003

Ono presents novel PPARalpha/PPARgamma agonists for diabetes and lipoprotein disorders

Feb. 17, 2003

New antidiabetic agents discovered at Toray

Feb. 14, 2003

Novel antidiabetic agents identified at Dr. Reddy's Research Foundation

Feb. 13, 2003

New glucokinase activators under study at AstraZeneca

Feb. 13, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.